Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.
Impact
The enactment of S09985 will modify existing public health and education laws to incorporate new standards for drug labeling and information accessibility. By mandating that pharmacies make supply chain details available at the point of dispensing, this bill aims to foster greater accountability and trust among patients and healthcare providers. It complements ongoing federal initiatives like the CLEAR LABELS Act, thereby aligning state practices with national standards for pharmaceutical transparency.
Summary
Bill S09985, also known as the 'Foreign Drug Transparency Act', is designed to enhance transparency in the prescription drug supply chain by requiring clear disclosure of the origin and manufacturer of prescription medications. The bill mandates that pharmacy benefit managers maintain and provide accessible supply chain information to pharmacies, health plans, and patients. The legislative intent is to ensure that vital information regarding the drugs that patients receive is readily available, particularly in a globalized market where many drugs are manufactured outside the United States.
Contention
While proponents argue that the bill will empower consumers and improve healthcare choices, concerns have been raised regarding the practical implementation of these requirements. Issues such as the potential burden on pharmacies and the additional costs associated with compliance are points of contention. Critics also debate whether these measures will significantly enhance patient safety or merely serve bureaucratic interests without yielding substantive benefits to the public.
Same As
Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.
Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.
To Prohibit Pharmaceutical Manufacturers From Restricting Or Limiting Prescription Medications To A Limited Distribution Network Of Out-of-state Pharmacies.